Legal Opinion
Sanofi-Aventis U.S. LLC v. Food and Drug Administration
District Court, District of Columbia
Decided February 7, 2012No. Civil Action No. 2010-1255PublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM OPINION
AMY BERMAN JACKSON, District Judge.
Plaintiff Sanofi-Aventis U.S. LLC (“Sanofi”) brought this action against the Food and Drug Administration (“FDA”), its Commissioner of Food and Drugs, Margaret A. Hamburg, and the Secretary of Health and Human Services, Kathleen Sebelius, alleging that FDA exceeded its statutory authority under the Federal Food, Drug, and Cosmetic Act (“FDCA”) and unlawfully departed from agency precedent when it approved a generic version of the Sanofi drug Lovenox. Sandoz, Inc. (“Sandoz”), the manufacturer of the generic drug, intervened as a defendant,…
2Cases cited23 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Pilot Life Insurance v. DedeauxSupreme Court of the United States · 1987
18 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Astrazeneca Pharmaceuticals Lp v. Food and Drug AdministrationDistrict Court, District of Columbia · 2012
- Takeda Pharmaceuticals, U.S.A., Inc. v. BurwellDistrict Court, District of Columbia · 2015
- Amgen Inc. v. HarganCourt of Appeals for the D.C. Circuit · 2018
- Amgen Inc. v. PriceDistrict Court, District of Columbia · 2018
- Vanda Pharmaceuticals, Inc. v. Centers for Medicare & Medicaid ServicesDistrict Court, D. Maryland · 2023